Discover 749 paid clinical trials in Sacramento, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 749
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
for
Locally Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Sacramento CA, Aurora CO
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06211335
Phase1, Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Sacramento CA, Dallas TX, San Antonio TX, Houston TX,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase1, Recruiting
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumor
Location: Sacramento CA, Santa Monica CA, Nashville TN,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05785741
Phase1, Phase2, Recruiting
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
for
Metastatic Cancer
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06389123
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
for
Metastatic Non-small Cell Lung Cancer
Location: Sacramento CA, Seattle WA, Houston TX, Nashville TN,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT04410796
Phase2, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: Sacramento CA, Stanford CA, Orange CA, Seattle WA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05384626
Phase1, Phase2, Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Sacramento CA, San Francisco CA, Los Angeles CA,
Sponsor: Clasp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06778863
Phase1, Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
for
Non-small Cell Lung Cancer
Location: Sacramento CA, Reno NV, Santa Monica CA, Tucson AZ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06561386
Phase3, Recruiting
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
for
Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II,
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06268665
Phase2, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Sacramento CA, Stanford CA, Los Angeles CA, Duarte CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase1, Recruiting
XTX301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Sacramento CA, Saint Louis Park MN, St Louis MO,
Sponsor: Xilio Development, Inc.
Sex: All
Age: 18+
Code: NCT05684965
Phase1, Phase2, Recruiting
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)